Skip to main content
Drug Development
Our Pipeline
Evaluation Pipeline
Inaphaea BioLabs
Therapeutic areas
Partnering
Useful Links
News
Investors
Regulatory News
AIM Rule 26
Annual and Half Yearly Reports
Admission Document & Articles
Investments Calculator
Share Alerts
Share Series
Share price look-up
Analyst Research
About us
Board of Directors and Management Team
Scientific Advisory Board
Strategy and Vision
How we work
Working with us
Collaborative Pipeline
Contact us
Search
News
Breadcrumb
News
Category
Articles
Events and presentations
News
Press releases
Videos and audiocasts
Articles
Meet the ValiRx team: Zai Ahmad
3 Apr 2023
News
Spring Budget key messages: R&D tax relief rate
30 Mar 2023
News
ValiRx CEO attends Treasury Connect: Life Sciences Conference
30 Mar 2023
Videos and audiocasts
ValiRx Investor Webinar Presentation with Q&A held on 8th March 2023
9 Mar 2023
Articles
International Women’s Day 2023: carving out a career in the life sciences
8 Mar 2023
News
ValiRx bolsters Inaphaea with trio of appointments
6 Mar 2023
Articles
Meet the ValiRx team: Mark Treharne
27 Feb 2023
Videos and audiocasts
Operational Update Videocast
31 Jan 2023
News
ValiRx appoints permanent Chief Scientific Officer
31 Jan 2023
News
ValiRx signals launch of new strategy with Nottingham laboratories
31 Jan 2023
Videos and audiocasts
Question and Answer Videocast
26 Jan 2023
Articles
ValiRx quarterly Q&A webinar: key questions answered
20 Jan 2023
Articles
Meet the ValiRx team: Dr Kevin Cox
18 Jan 2023
Articles
Accelerating early stage, academic innovation: the Cytolytix story so far
4 Jan 2023
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Current page
3
Page
4
Page
5
Page
6
Next page
Next
Last page
Last
